Effect of Interferential l Therapy on Low Back Pain

Low Back Pain Clinical Trial

— [PTREC]  

Official title:

Effect of Interferential Therapy on Pain, Range of Motion and Quality of Life in Patients With Chronic Non-specific Low Back Pain: A Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03961477
• Other study ID #: P.T REC/012/001811
• Status: Completed
• Phase: N/A
• Start date: December 5, 2017
• Est. completion date: September 23, 2018

Study information

• Verified date: May 2019
• Source: Ahlia University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Background: Chronic non-specific low back pain is defined as unknown mechanical musculoskeletal pain lasting more than 3 months. Electrotherapy is a non-pharmacologic, non-invasive and simple method back pain treatment that is mainly applied using interferential (IF) therapy. The current study was designed to investigate the effect of IF on pain, range of motion, and quality of life in patients with chronic non-specific low back pain. Materials and methods: 61 patients suffered from chronic non-specific low back pain (CNLBP) were randomly assigned to IF group (n=30) and placebo IF (n=31). The entire patient received suggested exercise 3 times per week for 4 weeks. The outcome measures were visual analogue scale (VAS), lumbar range of motion (ROM) in terms of flexion& extension and the Short Form-36 (SF-36) health questionnaire to evaluate the quality of life (QOL).

Description:

Participants The study was conducted in outpatient clinics in Cairo University Hospitals. 60 patients (29 males and 31 females) were invited to participate in the current study. Subjects were included in the study if they had LBP of at least three months duration and aged between 25 and 60 years. Patients with spinal pathology (tumor, nerve root, fracture, and compromise), cardiopulmonary conditions, pregnancy, and received physiotherapy in the last eight weeks or any contraindications to the use of electrotherapy were excluded.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 61
• Est. completion date: September 23, 2018
• Est. primary completion date: July 11, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 60 Years

Eligibility

Inclusion Criteria:

*Subjects were included in the study if they had LBP of at least three months duration * Age between 25 and 60 years.

Exclusion Criteria:

• Patients with spinal pathology (tumor, nerve root, fracture, and compromise),

• Cardiopulmonary conditions

• Pregnancy,

• Received physiotherapy in the last eight weeks

• Any contraindications to the use of electrotherapy were excluded.

Related Conditions & MeSH terms

• Back Pain
• Low Back Pain

Intervention

Other:
• Interferential therapy
Exercise therapy

Locations

Country	Name	City	State
Egypt	Dr Dalia Kamel	Giza
Egypt	Dr Sayed Tanatwy	Giza

Sponsors (2)

Lead Sponsor	Collaborator
Ahlia University	Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analogue Scale (VAS)	The severity of pain was evaluated using a visual analogue scale (VAS). The participants were requested to put a line on the scale perpendicularly that matched to their pain intensity. VAS scores represent the pain intensity as none, mild, moderate, or severe. The accompanying cutoff was used for the pain scale: 0- 4 , no pain; 5- 44, mild pain; 45- 74, moderate pain; and 75-100, severe pain	6 months